COMP <GO>
CRI vs CPRI // EV/EBITDA & P/E VALUATION
Carter's Inc. (NYSE) VS. Capri Holdings Limited (NYSE) • 15-METRIC TALLY: CRI 9
— CPRI 4
▲ EV/EBITDA & P/E VALUATION LEADER: CRI
LAST: $33.38 (+7.54%) • MKT CAP: $1.23B
valuation
6.9x
LAST: $16.06 (+5.04%) • MKT CAP: $1.83B
valuation
24.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRI VS. CPRI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CRI | CPRI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.40% | 62.30% | -16.90 | CPRI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.30% | 10.40% | +0.90 | CRI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 6.9x | 24.8x | -17.90 | CRI | /valuation <GO> |
| Free Cash Flow Yield | 5.60% | 0.77% | +4.83 | CRI | /fcf-yield <GO> |
| Operating Margin | 5.00% | 0.70% | +4.30 | CRI | /operating-margins <GO> |
| Net Profit Margin | 3.20% | 2.30% | +0.90 | CRI | /net-margins <GO> |
| Revenue Growth (YoY) | 1.90% | -4.10% | +6.00 | CRI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.60% | 0.00% | +4.60 | CRI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.63 | 3.32 | -0.69 | CPRI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | CRI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.1 | 73.3 | -26.21 | CPRI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.4x | 21.5x | -9.10 | CRI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.23B | $1.83B | -$599.8M | CPRI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CRI REV | CPRI REV | CRI GROSS % | CPRI GROSS % | CRI FCF | CPRI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.90B | $3.47B | 45.4% | 62.3% | $68.6M | $14.0M |
| FY 2024 | $2.84B | $3.62B | 48.0% | 62.2% | $242.6M | $207.0M |
| FY 2023 | $2.95B | $4.14B | — | — | $529.1M | $309.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRI // BETA —
CPRI // BETA —